Nebula Research & Development LLC Has $1.47 Million Holdings in The Allstate Co. (NYSE:ALL)

Nebula Research & Development LLC decreased its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 61.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,614 shares of the insurance provider's stock after selling 12,194 shares during the quarter. Nebula Research & Development LLC's holdings in Allstate were worth $1,468,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. Hancock Whitney Corp grew its position in Allstate by 30.8% in the 4th quarter. Hancock Whitney Corp now owns 97,095 shares of the insurance provider's stock worth $18,719,000 after purchasing an additional 22,871 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. acquired a new stake in Allstate in the 4th quarter valued at approximately $8,445,000. Adage Capital Partners GP L.L.C. boosted its position in Allstate by 21.9% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 297,419 shares of the insurance provider's stock worth $57,339,000 after acquiring an additional 53,500 shares during the period. Syon Capital LLC grew its stake in shares of Allstate by 4.1% in the fourth quarter. Syon Capital LLC now owns 2,293 shares of the insurance provider's stock worth $442,000 after purchasing an additional 90 shares in the last quarter. Finally, Pinebridge Investments L.P. raised its stake in shares of Allstate by 11.3% during the fourth quarter. Pinebridge Investments L.P. now owns 138,893 shares of the insurance provider's stock valued at $26,777,000 after purchasing an additional 14,128 shares in the last quarter. Institutional investors own 76.47% of the company's stock.

Insider Activity at Allstate

In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the business's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the transaction, the chief financial officer now owns 18,115 shares in the company, valued at $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.80% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ALL has been the topic of several research analyst reports. Evercore ISI raised shares of Allstate from an "in-line" rating to an "outperform" rating in a research note on Wednesday, January 8th. Argus upgraded shares of Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. Keefe, Bruyette & Woods decreased their price target on Allstate from $240.00 to $228.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. StockNews.com downgraded Allstate from a "buy" rating to a "hold" rating in a research note on Friday, April 18th. Finally, Barclays decreased their target price on Allstate from $183.00 to $172.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $219.27.

Allstate Trading Up 1.4 %

ALL traded up $2.65 during trading on Monday, reaching $195.56. The company had a trading volume of 1,504,093 shares, compared to its average volume of 1,615,202. The firm's 50-day simple moving average is $197.70 and its 200 day simple moving average is $194.74. The company has a market cap of $51.85 billion, a price-to-earnings ratio of 11.51, a PEG ratio of 1.01 and a beta of 0.36. The Allstate Co. has a 12-month low of $156.66 and a 12-month high of $212.91. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Equities research analysts anticipate that The Allstate Co. will post 18.74 earnings per share for the current year.

Allstate announced that its Board of Directors has approved a stock buyback plan on Wednesday, February 26th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the insurance provider to buy up to 3% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its stock is undervalued.

Allstate Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 10th were issued a dividend of $1.00 per share. This is a boost from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 annualized dividend and a dividend yield of 2.05%. The ex-dividend date of this dividend was Monday, March 10th. Allstate's dividend payout ratio (DPR) is currently 23.54%.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.